Owens David (CIK 1916664) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-09-30). Recent activity: Buy NXL (36,459 shares), Buy NXL (1,000 shares), Buy NXL (1,000 shares), Buy NXL (1,000 shares), Buy NXL (1,500 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-09-30 | Nexalin Technology, Inc. (NXL) | Chief Medical Officer | Buy | 36,459 | $0 |
| 2025-02-05 | Nexalin Technology, Inc. (NXL) | Chief Medical Officer | Buy | 1,000 | $3,100 |
| 2025-02-04 | Nexalin Technology, Inc. (NXL) | Chief Medical Officer | Buy | 1,000 | $2,980 |
| 2025-01-29 | Nexalin Technology, Inc. (NXL) | Chief Medical Officer | Buy | 1,000 | $2,750 |
| 2025-01-29 | Nexalin Technology, Inc. (NXL) | Chief Medical Officer | Buy | 1,500 | $4,050 |
| 2025-01-24 | Nexalin Technology, Inc. (NXL) | Chief Medical Officer | Buy | 2,000 | $5,000 |
| 2025-01-24 | Nexalin Technology, Inc. (NXL) | Chief Medical Officer | Buy | 1,000 | $2,700 |
Source: SEC Form 4 filings · as of 2025-09-30